Animals usually use photoperiod as an important environmental cue to time the year. In terms of the winter immunocompetence enhancement hypothesis, animals in the non-tropical zone would actively enhance their immune function to decrease the negative influence of stressors such as low temperature and food shortage in winter. In the
Animals usually use photoperiod as an important environmental cue to time the year. In terms of the winter immunocompetence enhancement hypothesis, animals in the non-tropical zone would actively enhance their immune function to decrease the negative influence of stressors such as low temperature and food shortage in winter. In the present study, we mimicked the transition from summer to winter by decreasing photoperiod gradually and examined the variations of immune repsonses in Siberian hamsters (Phodopus sungorus) to test this hypothesis. Twenty two female adult hamsters were randomly divided into the control (12h light: 12h dark, Control, n=11) and the gradually decreasing photoperiod group (Experiment, n=11). In the experiment group, day length was decreased from 12 h: 12 h light-dark cycle to 8 h: 16 h light-dark cycle at the pace of half an hour per week. We found that gradually decreasing photoperiod had no effect on body composition (wet carcass mass, subcutaneous, retroperitoneal, mesenteric and total body fat mass) and the masses of the organs detected such as brain, heart, liver and so on in hamsters. Similarly, immunological parameters including immune organs (thymus and spleen), white blood cells and serum bacteria killing capacity indicative of innate immunity were also not influenced by gradually decreasing photoperiod, which did not support the winter immunocompetence enhancement hypothesis. However, gradually decreasing photoperiod increased phytohaemagglutinin response post-24h of PHA challenge, which supported this hypothesis. There was no correlation between cellular, innate immunity and body fat mass, suggesting that body fat was not the reasons of the changes of cellular immunity. In summary, distinct components of immune system respond to gradually decreasing photoperiod differently in Siberian hamsters. Full article
Nelson, R.J. 2004. Seasonal immune function and sickness responses. Trends Immunol. 25, 187-192.
Dobrowolska, A., Adamczewska-Andrzejewska, K.A., 1991. Seasonal and long term changes in serum gamma globulin levels in comparing the physiology and population density of the common vole, Microtus arvalis Pall.1779. J. Interdis. Cycle Res, 22, 1-19.
Moshkin, M.P., Dobrotvorsky, A.K., Mak, V.V., Panov, V.V., Dobrotvorskaya, E.A., 1998. Variability of immune response to heterologous erythrocytes during population cycles of red (Clethrionom ys rutilus) and bank (C. glareolus) voles. Oikos 82, 131-138.
Sinclair, J.A., Lochmiller, R.L., 2000. The winter immunoenhancement hypothesis: associations among immunity, density, and survival in Prairie vole (Microtus ochrogaster) populations. Can. J. Zool. 78, 254-264.
Zhang, Z.Q., Wang, D.H., 2006. Seasonal changes in immune function, body fat mass and organ mass in Mongolian gerbils (Meriones unguiculatus). Acta, Theriol. Sin.26,338-345. (In Chinese with English summary).
Newson, J., 1962. Seasonal differences in reticulocyte count, hemoglobin levels and spleen weight in wild voles. Bri. J. Haemat.8, 296-302.
Lochmiller RL, VesteyM R, McMurry ST. 1994. Temporal variation in humoral and cell-mediated immune response in a Sigmodon hispidus population. Ecology 75: 236-245.
Mann DR, Akinbami MA, Gould KG, Ansari AA. 2000. Seasonal variations in cytokine expression and cell-mediated immunity in male rhesus monkeys. Cell Immunol 200: 105-115.
Brainard, G.C., Knobler, R.I., Podolin, P.L., Lavasa, M., Lubin, F.D., 1987. Neuroimmunology: modulation of the hamster immune system by photoperiod. Life Sci.40, 1319-1326.
Drazen, D.L., Jasnow, A.M., Nelson, R.J., Demas, G.E.. 2002. Exposure to short days, but not short-term melatonin, enhances humoral immunity of male Syrian hamsters (Mesocricetus auratus) J. Pineal Res. 33, 118-124.
Bilbo, S.D., Dhabhar, F.S., Viswanathan, K., Saul, A., Yellon, S.M., Nelson,R.J., 2002. Short day lengths augment stress-induced leukocyte trafficking and stress-induced enhancement of skin immune function. Proc. Natl. Acad. Sci. 99, 4067- 4072.
Yellon, S.M., Fagoaga, O.R., Nehlsen-Cannarella, S.L., 1999. Influence of photoperiod on immune cell functions in the male Siberian hamster. Am. J. Physiol. 276, R97-R102.
Drazen, D.L., Kriegsfeld, L.J., Schneider, J.E., Nelson, R.J., 2000. Leptin, but not immune function, is linked to reproductive responsiveness to photoperiod. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278, R1401-R1407.
Tieleman BI, Williams JB, Ricklefs RE, Klasing KC, (2005). Constitutive innate immunity is a component of the pace-of-life syndrome in tropical birds. Proc.Roy. Soc.B 272, 1715-1720.
Demas GE, Zysling DA, Beechler BR, Muehlenbein MP, French SS. (2011). Beyond phytohaemagglutinin: assessing vertebrate immune function across ecological contexts. JAnim. Ecol.80, 710-730.
Xu DL, Hu XK. 2017. Photoperiod and temperature differently affect immune function in striped hamsters (Cricetulus barabensis). Comp. Physiol. Part A 204: 211-218.
Bellocq, J.G., Krasnov, B.R., Khokhlova, I.S., Pinshow, B., 2006. Temporal dynamics of a T-cell mediated immune response in desert rodents. Comp. Biochem. Physiol. A 145, 554-559.
Calder, P.C., Kew, S., 2002. The immune system: a target for functional foods? Bri. J. Nutr. 88, S165-S176.
Savino, W., Dardenne, M., 2000. Neuroendocrine control of thymus physiology. Endocr. Rev. 21, 412-443.
Smith KG, Hunt JL (2004). On the use of spleen mass as a measure of avian immune system strength. Oecologia 138, 28-31.
Ahima R.S., J.S. Flier., 2000. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab.11, 327-332.
Fantuzzi, G., 2005. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol.115, 911-919.
Sch?ffler A, Sch?lmerich J, Salzberger B (2007). Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. TrendsImmunol.28, 393-99.
Dong WH, Hou XX, Zhang PL, Zhou YL, Yang YP, Xue XP (1990). A study on population quantity compostion and reproduction of striped hairy-footed hamster. Acta Theriol. Sin. 1990, 10(3):221-226. (In Chinese with English abstract)
Dong WH, Hou XX, Zhou YL, Zhang YX, Lang BJ, Xue XP. (1998). Studies on population dynamics and prediction of Phodopus sungorus. Acta Agrest Sinica.. 6(3):207-211. (In Chinese with English abstract)
Demas GE. (2002) Splenic denervation blocks leptin induced enhancement of humoral immunity in Siberian hamsters (Phodopus sungorus). Neuroendocrinology76, 178-184.
Xu DL, Hu XK, Tian YF (2017). Effect of temperature and food restriction on immune function in striped hamsters (Cricetulus barabensis). JExp. Biol.doi:10.1242/jeb.153601.
Gatien ML, Hotchkiss AK, Dhabhar FS, Nelson RJ. 2005. Skeleton photoperiods alter delayed-type hypersensitivity responses and reproductive function of siberian hamsters (Phodopus sungorus). J Neuroendocri.17: 733?739.
Demas G.E., Nelson R.J. 2003. Lack of immunological responsiveness to photoperiod in a tropical rodent, Peromyscus aztecus hylocetes. J Comp. Physiol. B 173: 171?176.
Yellon, S.M., 2007. Melatonin mediates photoperiod control of endocrine adaptationsand humoral immunity in male Siberian hamsters. J. Pineal Res. 43, 109-114.
Weil, Z.M., Borniger, J.C., Cisse, Y.M., Salloum, B.A., Nelson, R.J., 2015. Neuroendocrine control of photoperiodic changes in immune function. Front. Neuroendocr. 37,108-118.
Objective: This study aimed to determine whether perioperative antiviral treatment is facilitate for patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and Child-Pugh grade A cirrhosis in perioperative recovery of liver function and HBV activation. Methods: The study included 115 patients with HBV-related HCC and Child-Pugh grade A cirrhosis
Objective: This study aimed to determine whether perioperative antiviral treatment is facilitate for patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and Child-Pugh grade A cirrhosis in perioperative recovery of liver function and HBV activation. Methods: The study included 115 patients with HBV-related HCC and Child-Pugh grade A cirrhosis who underwent resection. Patients were prospectively assigned to a preoperative antiviral treatment group (n = 51) or postoperative antiviral treatment group (n = 52); twelve patients who had not received antiviral treatment before and after surgery were designated a non-treatment group (n = 12). HBV reactivation during a month after the operation was defined as a HBV DNA value tenfold over preoperative values. Postoperative liver dysfunction was defined as prothrombin activity <50% and serum bilirubin >50 mmol/L on postoperative day 5. Results: Postoperatively, liver dysfunction was present in 1 of 51 (1.96%) patients who received preoperative antiviral therapy, 1 of 52 (1.92%) who received postoperative therapy, and 3 of 12 (25%) who received no antiviral therapy. HBV reactivation postoperatively occurred at similar rates. Conclusions: Preoperative and postoperative antiviral treatment of patients with Child-Pugh grade A cirrhosis and high levels of HBV DNA undergoing hepatic resection for HCC are both facilitate in preventing perioperative liver dysfunction and reactivation of HBV. Thus, in this population with high levels of HBV DNA, perioperative antiviral treatment is important. Full article
Huang L, Li J, Yan J, Sun J, Zhang X, Wu M, et al. Antiviral therapy decreases viral reactivation in patients with hepatitis B virus-related hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trial. Journal of viral hepatitis. 2013;20(5):336-342.
Kuzuya T, Katano Y, Kumada T, Toyoda H, Nakano I, Hirooka Y, et al. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Journal of gastroenterology and hepatology. 2007;22(11):1929-1935.
Piao CY, Fujioka S, Iwasaki Y, Fujio K, Kaneyoshi T, Araki Y, et al. Lamivudine treatment in patients with HBV-related hepatocellular carcinoma--using an untreated, matched control cohort. Acta Med Okayama. 2005;59(5):217-224.
Zhang B, Xu D, Wang R, Zhu P, Mei B, Wei G, et al. Perioperative antiviral therapy improves safety in patients with hepatitis B related HCC following hepatectomy. Int J Surg. 2015;15:1-5.
Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, et al. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Annals of surgery. 2013;257(3):490-505.
Shuqun C, Mengchao W, Han C, Feng S, Jiahe Y, Wenming C, et al. Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection. Hepatogastroenterology. 2006;53(68):249-252.
Li N, Lai EC, Shi J, Guo WX, Xue J, Huang B, et al. A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection. Annals of surgical oncology. 2010;17(1):179-185.
Chuma M, Hige S, Kamiyama T, Meguro T, Nagasaka A, Nakanishi K, et al. The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma. Journal of gastroenterology. 2009;44(9):991-999.
Chan AC, Chok KS, Yuen WK, Chan SC, Poon RT, Lo CM, et al. Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma. Arch Surg. 2011;146(6):675-681.
Zhou Y, Zhang Z, Zhao Y, Wu L, Li B. Antiviral therapy decreases recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection: a meta-analysis. World journal of surgery. 2014;38(9):2395-2402.
Sakamoto K, Beppu T, Hayashi H, Nakagawa S, Okabe H, Nitta H, et al. Antiviral therapy and long-term outcome for hepatitis B virus-related hepatocellular carcinoma after curative liver resection in a Japanese cohort. Anticancer Res. 2015;35(3):1647-1655.
Chong CC, Wong GL, Wong VW, Ip PC, Cheung YS, Wong J, et al. Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study. Aliment Pharmacol Ther. 2015;41(2):199-208.
Wu CY, Lin JT, Ho HJ, Su CW, Lee TY, Wang SY, et al. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study. Gastroenterology. 2014;147(1):143-151 e145.
Ke Y, Ma L, You XM, Huang SX, Liang YR, Xiang BD, et al. Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy. Cancer biology & medicine. 2013;10(3):158-164.
Kubo S, Tanaka H, Takemura S, Yamamoto S, Hai S, Ichikawa T, et al. Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus. Hepatology research : the official journal of the Japan Society of Hepatology. 2007;37(2):94-100.
Wei Q, Xu X, Ling Q, Zhou B, Zheng SS. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2013;12(3):251-255.
Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1-98.
Liaw YF, Kao JH, Piratvisuth T, Chan HL, Chien RN, Liu CJ, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int. 2012;6(3):531-561.
Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Annals of surgery. 2005;242(6):824-828, discussion 828-829.
Dan JQ, Zhang YJ, Huang JT, Chen MS, Gao HJ, Peng ZW, et al. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2013;39(8):865-872.
Lee JI, Kim JK, Chang HY, Lee JW, Kim JM, Chung HJ, et al. Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus. Journal of gastroenterology and hepatology. 2014;29(5):1019-1027.
Huang L, Li J, Lau WY, Yan J, Zhou F, Liu C, et al. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma. Journal of gastroenterology and hepatology. 2012;27(1):158-164.
Wang JP, Kao FY, Wu CY, Hung YP, Chao Y, Chou YJ, et al. Nucleos(t)ide analogues associated with a reduced risk of hepatocellular carcinoma in hepatitis B patients: a population-based cohort study. Cancer. 2015;121(9):1446-1455.
Xia BW, Zhang YC, Wang J, Ding FH, He XD. Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: A systematic review and meta-analysis. Clinics and research in hepatology and gastroenterology. 2015; 39(4):458-68.